Effect of Reversible Pulmonary Hypertension on Outcomes After Heart Transplantation

Journal of Heart and Lung Transplantation

Volumn 26, Issue 4, 2007, Pages 319-323

  Drakos, Stavros G ^a,b   Kfoury, Abdallah G ^a   Gilbert, Edward M ^b,c   Horne, Benjamin D ^a   Long, James W ^a   Stringham, James C ^b,c   Campbell, Beverly A ^a   Renlund, Dale G ^a,b  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MILRINONE; NITRIC ACID DERIVATIVE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ADULT; ARTICLE; DEATH; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PULMONARY HYPERTENSION; RECIPIENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ADULT; FEMALE; HEART DISEASES; HEART TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 33947622681     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.01.012     Document Type: Article

References (20)

1. Costard-Jackie A., and Fowler M.B. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 19 (1992) 48-54
2. Kirklin J.K., Naftel D.C., Kirklin J.W., Blackstone E.H., White-Williams C., and Bourge R.C. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 7 (1988) 331-336
3. Natale M.E., and Pina I.L. Evaluation of pulmonary hypertension in heart transplant candidates. Curr Opin Cardiol 18 (2003) 136-140
4. Chen J.M., Levin H.R., Michler R.E., Prusmack C.J., Rose E.A., and Aaronson K.D. Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg 114 (1997) 627-634
5. Butler J., Stankewicz M.A., Wu J., et al. Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. J Heart Lung Transplant 24 (2005) 170-177
6. Klotz S., Deng M.C., Hanafy D., et al. Reversible pulmonary hypertension in heart transplant candidates-pretransplant evaluation and outcome after orthotopic heart transplantation. Eur J Heart Fail 5 (2003) 645-653
7. Zakliczynski M., Zebik T., Maruszewski M., Swierad M., and Zembala M. Usefulness of pulmonary hypertension reversibility test with sodium nitroprusside in stratification of early death risk after orthotopic heart transplantation. Transplant Proc 37 (2005) 1346-1348
8. Baldovinos A., Kalangos A., Sierra J., Licker M.J., and Faidutti B. Is partially reversible pulmonary hypertension a contraindication for heart transplantation?. Transplant Proc 32 (2000) 468-469
9. Espinoza C., Manito N., Roca J., et al. Reversibility of pulmonary hypertension in patients evaluated for orthotopic heart transplantation: importance in the postoperative morbidity and mortality. Transplant Proc 31 (1999) 2503-2504
10. Butler J., Chomsky D.B., and Wilson J.R. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol 34 (1999) 1802-1806
11. Abramson S.V., Burke J.F., Kelly Jr. J.J., et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 116 (1992) 888-895
12. Ghio S., Gavazzi A., Campana C., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 37 (2001) 183-188
13. Carrier M., Rivard M., Latter D., and Kostuk W. Predictors of early mortality after heart transplantation: the Canadian transplant experience from 1981 to 1992. The CASCADE Investigators. Canadian Study of Cardiac Transplant Atherosclerosis Determinants. Can J Cardiol 14 (1998) 703-707
14. McCarthy J.F., McCarthy P.M., Massad M.G., et al. Risk factors for death after heart transplantation: does a single-center experience correlate with multicenter registries?. Ann Thorac Surg 65 (1998) 1574-1579
15. Costanzo M.R., Augustine S., Bourge R., et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 92 (1995) 3593-3612
16. Tsai F.C., Marelli D., Bresson J., et al. Recent trends in early outcome of adult patients after heart transplantation: a single-institution review of 251 transplants using standard donor organs. Am J Transplant 2 (2002) 539-545
17. Bourge R.C., Naftel D.C., Costanzo-Nordin M.R., et al., The Transplant Cardiologists Research Database Group. Pretransplantation risk factors for death after heart transplantation: a multi institutional study. J Heart Lung Transplant 12 (1993) 549-562
18. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 24 (2005) 945-955
19. Klotz S., Schmid C., and Scheld H.H. Reversible pulmonary hypertension in heart transplant candidates does not obligatorily predict worse outcome post-transplantation. J Heart Lung Transplant 24 (2005) 1998-1999
20. Tenderich G., Koerner M.M., Stuettgen B., et al. Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient >15 mm Hg or >5 wood) predict early and long-term results after orthotopic heart transplantation?. Transplant Proc 30 (1998) 1130-1131